Study of AZD6094 (Volitinib) in Advanced Gastric Adenocarcinoma Patients With MET Amplification as a Third-line Treatment
Clinical trial NCT02449551 · COMPLETED
Trial details
- NCT number
- NCT02449551
- Sponsor
- Samsung Medical Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-10
- Primary completion
- 2020-12-30
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.